Economic evaluation of different treatment modalities in acute kidney injury

Nephrology Dialysis Transplantation

Volumn 27, Issue 11, 2012, Pages 4095-4101

  De Smedt, Delphine M ^a,b   Elseviers, Monique M ^c   Lins, Robert L ^c   Annemans, Lieven ^a,b,d  

^a GHENT UNIVERSITY   (Belgium)

^b Interuniversity Centre of Health Economics   (Belgium)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d FACULTY OF MEDICINE AND PHARMACY   (Belgium)

Author keywords

acute kidney injury; cost effectiveness; renal replacement therapy; SHARF

Indexed keywords

ACUTE KIDNEY FAILURE; ARTICLE; BELGIUM; CONSERVATIVE TREATMENT; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; ECONOMIC EVALUATION; FOLLOW UP; HEALTH CARE COST; HOSPITALIZATION COST; HUMAN; INTERMETHOD COMPARISON; INTERMITTENT RENAL REPLACEMENT THERAPY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; SENSITIVITY ANALYSIS;

ACUTE KIDNEY INJURY; AREA UNDER CURVE; BELGIUM; COST-BENEFIT ANALYSIS; HOSPITAL COSTS; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MODELS, ECONOMIC; RENAL REPLACEMENT THERAPY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84869459509     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfs410     Document Type: Article

References (33)

1. de Mendonca A, Vincent JL, Suter PM et al. Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score. Intensive Care Med 2000; 26:915-921. (Pubitemid 30618015)
2. Ympa YP, Sakr Y, Reinhart K et al. Has mortality from acute renal failure decreased? A systematic review of the literature. Am J Med 2005; 118:827-832. (Pubitemid 41097456)
3. Chertow GM, Burdick E, Honour M et al. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005; 16:3365-3370. (Pubitemid 46179340)
4. Van Berendoncks AM, Elseviers MM, Lins RL. Outcome of acute kidney injury with different treatment options: long-term follow-up. Clin J Am Soc Nephrol 2010; 5:1755-1762.
5. Ghahramani N, Shadrou S, Hollenbeak C. A systematic review of continuous renal replacement therapy and intermittent haemodialysis in management of patients with acute renal failure. Nephrology (Carlton) 2008; 13:570-578.
6. Prowle JR, Bellomo R. Continuous renal replacement therapy: recent advances and future research. Nat Rev Nephrol 2010; 6:521-529.
7. Rabindranath K, Adams J, Macleod AM et al. Intermittent versus continuous renal replacement therapy for acute renal failure in adults. Cochrane Database Syst Rev 2007; CD003773
8. Van Biesen W, Vanholder R, Lameire N. Dialysis strategies in critically ill acute renal failure patients. Curr Opin Crit Care 2003; 9:491-495. (Pubitemid 37518648)
9. Jakob SM, Frey FJ, Uehlinger DE. Does continuous renal replacement therapy favourably influence the outcome of the patients? Nephrol Dial Transplant 1996; 11:1250-1255. (Pubitemid 26241411)
10. Kanagasundaram NS, Paganini EP. Critical care dialysis-a Gordian knot (but is untying the right approach?). Nephrol Dial Transplant 1999; 14:2590-2594. (Pubitemid 32208368)
11. Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transplant 2001; 16 (Suppl 5):67-72. (Pubitemid 32750433)
12. Mehta RL, McDonald B, Gabbai FB et al. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60:1154-1163. (Pubitemid 34207769)
13. Augustine JJ, Sandy D, Seifert TH et al. A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF. Am J Kidney Dis 2004; 44:1000-1007. (Pubitemid 39556479)
14. Uehlinger DE, Jakob SM, Ferrari P et al. Comparison of continuous and intermittent renal replacement therapy for acute renal failure. Nephrol Dial Transplant 2005; 20:1630-1637. (Pubitemid 41418587)
15. Vinsonneau C, Camus C, Combes A et al. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a mul-ticentre randomised trial. Lancet 2006; 368:379-385. (Pubitemid 44108121)
16. Tonelli M, Manns B, Feller-Kopman D. Acute renal failure in the intensive care unit: a systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 2002; 40:875-885. (Pubitemid 35265466)
17. Kellum JA, Angus DC, Johnson JP et al. Continuous versus intermittent renal replacement therapy: a meta-analysis. Intensive Care Med 2002; 28:29-37. (Pubitemid 34118972)
18. Lins RL, Elseviers MM, Van der Niepen P et al. Intermittent versus continuous renal replacement therapy for acute kidney injury patients admitted to the intensive care unit: results of a randomized clinical trial. Nephrol Dial Transplant 2009; 24:512-518.
19. Elseviers MM, Lins RL, Van der Niepen P et al. Renal replacement therapy is an independent risk factor for mortality in critically ill patients with acute kidney injury. Crit Care 2010; 14: R221
20. Briggs AH, Claxton K, Sculpher MJ. Decision Modelling for Health Economic Evaluation. Oxford: Oxford University Press, 2006.
21. Lins RL, Elseviers M, Daelemans R et al. Prognostic value of a new scoring system for hospital mortality in acute renal failure. Clin Nephrol 2000; 53:10-17. (Pubitemid 30046898)
22. Lins RL, Elseviers MM, Daelemans R et al. Re-evaluation and modification of the Stuivenberg Hospital Acute Renal Failure (SHARF) scoring system for the prognosis of acute renal failure: an independent multicentre, prospective study. Nephrol Dial Transplant 2004; 19:2282-2288. (Pubitemid 39214122)
23. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002; 21:271-292. (Pubitemid 34143147)
24. Johansen KL, Smith MW, Unruh ML et al. Predictors of health utility among 60-day survivors of acute kidney injury in the Veterans Affairs/National Institutes of Health Acute Renal Failure Trial Network Study. Clin J Am Soc Nephrol 2010; 5:1366-1372.
25. Morton RL, Howard K, Webster AC et al. The cost-effectiveness of induction immunosuppression in kidney transplantation. Nephrol Dial Transplant 2009; 24:2258-2269.
26. Messori A. Survival curve fitting using the Gompertz function: a methodology for conducting cost-effectiveness analyses on mortality data. Comput Methods Programs Biomed 1997; 52:157-164. (Pubitemid 27095058)
27. Palmer AJ. Health economics-what the nephrologist should know. Nephrol Dial Transplant 2005; 20:1038-1041. (Pubitemid 40862090)
28. Klarenbach S, Manns B, Pannu N et al. Economic evaluation of continuous renal replacement therapy in acute renal failure. Int J Technol Assess Health Care 2009; 25:331-338.
29. Hamel MB, Phillips RS, Davis RB et al. Outcomes and cost-effectiveness of initiating dialysis and continuing aggressive care in seriously ill hospitalized adults. SUPPORT investigators. Study to understand prognoses and preferences for outcomes and risks of treatments. Ann Intern Med 1997; 127:195-202. (Pubitemid 27332537)
30. Bell M, Granath F, Schon S et al. Continuous renal replacement therapy is associated with less chronic renal failure than intermittent haemodialysis after acute renal failure. Intensive Care Med 2007; 33:773-780. (Pubitemid 46675325)
31. Uchino S, Bellomo R, Kellum JA et al. Patient and kidney survival by dialysis modality in critically ill patients with acute kidney injury. Int J Artif Organs 2007; 30:281-292. (Pubitemid 46938852)
32. Ahlstrom A, Tallgren M, Peltonen S et al. Survival and quality of life of patients requiring acute renal replacement therapy. Intensive Care Med 2005; 31:1222-1228. (Pubitemid 41355799)
33. Whitehead SJ, Ali S. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull 2010; 96:5-21.